ArticleJournal of thoracic disease2025

Krebs von den Lungen-6 as a biomarker for distinguishing between interstitial lung disease and interstitial lung abnormalities based on computed tomography findings.

Jin Hwa Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.